VIIVA BIODERMA ACTIVES HGH CREAM- sus scrofa adrenal gland, thyroid, bovine, somatropin cream Estats Units - anglès - NLM (National Library of Medicine)

viiva bioderma actives hgh cream- sus scrofa adrenal gland, thyroid, bovine, somatropin cream

viiva llc - sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), thyroid, bovine (unii: mn18otn73w) (thyroid, bovine - unii:mn18otn73w), somatropin (unii: nqx9kb6pcl) (somatropin - unii:nqx9kb6pcl) - may improve sleep, bone and joint health, immune health and assist with increase of muscle and a reduction in fat*

TRADOREC XL Irlanda - anglès - HPRA (Health Products Regulatory Authority)

tradorec xl

hgh regulatory sciences limited - tramadol hydrochloride - tablet prolonged release - 100 milligram

TRADOREC XL Irlanda - anglès - HPRA (Health Products Regulatory Authority)

tradorec xl

hgh regulatory sciences limited - tramadol hydrochloride - tablet prolonged release - 200 milligram

TRADOREC XL 100 Milligram Tablet Prolonged Release Irlanda - anglès - HPRA (Health Products Regulatory Authority)

tradorec xl 100 milligram tablet prolonged release

hgh regulatory sciences limited - tramadol hydrochloride - tablet prolonged release - 100 milligram

TRADOREC XL 200 Milligram Tablet Prolonged Release Irlanda - anglès - HPRA (Health Products Regulatory Authority)

tradorec xl 200 milligram tablet prolonged release

hgh regulatory sciences limited - tramadol hydrochloride - tablet prolonged release - 200 milligram

Omnitrope Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

omnitrope

sandoz new zealand limited - somatropin 6.67 mg/ml - solution for injection - 10 mg/1.5ml - active: somatropin 6.67 mg/ml excipient: dibasic sodium phosphate glycine monobasic sodium phosphate phenol phosphoric acid poloxamer 188 sodium hydroxide water for injection - adults replacement therapy in adults with pronounced growth hormone deficiency as diagnosed in two different dynamic tests for growth hormone deficiency. patients must also fulfill the following criteria. childhood onset: patients, who were diagnosed as growth hormone deficient during childhood, must be retested and their growth hormone deficiency confirmed before replacement therapy is started. adult onset: patients must have growth hormone deficiency as a result of hypothalamic or pituitary disease and at least one other hormone deficiency diagnosed (except for prolactin) and adequate replacement therapy instituted, before replacement therapy using growth hormone may begin. prader-willi syndrome, for improvement of body composition.

Omnitrope Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

omnitrope

sandoz new zealand limited - somatropin 10 mg/ml - solution for injection - 15 mg/1.5ml - active: somatropin 10 mg/ml excipient: dibasic sodium phosphate monobasic sodium phosphate phenol phosphoric acid poloxamer 188 sodium chloride sodium hydroxide water for injection - adults replacement therapy in adults with pronounced growth hormone deficiency as diagnosed in two different dynamic tests for growth hormone deficiency. patients must also fulfill the following criteria. childhood onset: patients, who were diagnosed as growth hormone deficient during childhood, must be retested and their growth hormone deficiency confirmed before replacement therapy is started. adult onset: patients must have growth hormone deficiency as a result of hypothalamic or pituitary disease and at least one other hormone deficiency diagnosed (except for prolactin) and adequate replacement therapy instituted, before replacement therapy using growth hormone may begin. prader-willi syndrome, for improvement of body composition.

Omnitrope Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

omnitrope

sandoz new zealand limited - somatropin 3.33 mg/ml - solution for injection - 5 mg/1.5ml - active: somatropin 3.33 mg/ml excipient: benzyl alcohol dibasic sodium phosphate mannitol monobasic sodium phosphate phosphoric acid poloxamer 188 sodium hydroxide water for injection - adults replacement therapy in adults with pronounced growth hormone deficiency as diagnosed in two different dynamic tests for growth hormone deficiency. patients must also fulfill the following criteria. childhood onset: patients, who were diagnosed as growth hormone deficient during childhood, must be retested and their growth hormone deficiency confirmed before replacement therapy is started. adult onset: patients must have growth hormone deficiency as a result of hypothalamic or pituitary disease and at least one other hormone deficiency diagnosed (except for prolactin) and adequate replacement therapy instituted, before replacement therapy using growth hormone may begin. prader-willi syndrome, for improvement of body composition.

VITAL HGH IMMUNE BOOSTER apis mellifica borax carduus marianus echinacea galium aparine hepar suis mercurius corrosivus spray Estats Units - anglès - NLM (National Library of Medicine)

vital hgh immune booster apis mellifica borax carduus marianus echinacea galium aparine hepar suis mercurius corrosivus spray

liddell laboratories - apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z) - apis mellifera 200 [hp_c] in 1 ml

VITAL HGH SKIN, HAIR AND NAILS amino acids apis mellifica biotin epidermis galium aparine hamamelis virginiana hepar suis natrum Estats Units - anglès - NLM (National Library of Medicine)

vital hgh skin, hair and nails amino acids apis mellifica biotin epidermis galium aparine hamamelis virginiana hepar suis natrum

liddell labroatories - amino acids (unii: 0o72r8rf8a) (amino acids - unii:0o72r8rf8a) - amino acids 10 [hp_x] in 1 ml